| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.044 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |